Cargando…

Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study

OBJECTIVES: The purpose of this study is to determine the therapeutic value of surgery in individuals with urinary bladder signet ring cell carcinoma (SRCC). Surgery has not been examined as a prognostic factor for urinary bladder cancer (SRCC). MATERIALS AND METHODS: Using the Surveillance, Epidemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Alradhi, Mohammed, Safi, Mohammed, Tao, Shenghua, Al-danakh, Abdullah, Almoiliqy, Marwan, Baldi, Salem, Li, Xiancheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003658/
https://www.ncbi.nlm.nih.gov/pubmed/35422880
http://dx.doi.org/10.1177/17562872221079473
_version_ 1784686177258831872
author Alradhi, Mohammed
Safi, Mohammed
Tao, Shenghua
Al-danakh, Abdullah
Almoiliqy, Marwan
Baldi, Salem
Li, Xiancheng
author_facet Alradhi, Mohammed
Safi, Mohammed
Tao, Shenghua
Al-danakh, Abdullah
Almoiliqy, Marwan
Baldi, Salem
Li, Xiancheng
author_sort Alradhi, Mohammed
collection PubMed
description OBJECTIVES: The purpose of this study is to determine the therapeutic value of surgery in individuals with urinary bladder signet ring cell carcinoma (SRCC). Surgery has not been examined as a prognostic factor for urinary bladder cancer (SRCC). MATERIALS AND METHODS: Using the Surveillance, Epidemiology, and End Results program (SEER), patients with urinary bladder SRCC who presented from 1975 to 2018 were included in a retrospective study. The effect of surgical therapy on cause-specific survival (CSS) and overall survival (OS) was examined using univariate and multivariate Cox regression models. We subdivided 595 patients with SRCC into 2 groups, as follows: 496 who underwent surgery; and 99 who did not undergo surgery. RESULTS: Males had high predominance in all cases in both groups (p = 0.04). Moderate and poor differentiation (III–IV) were observed in the majority of patients who underwent surgery (77.2 vs 58.6, p ⩽ 0.001) and had no insurance (p ⩽ 0.001). By using KM, the OS and CSS of the surgery group were found to be significantly better than those of the non-surgery group (p  = 0.001,%) after adjusting for the variables of age, race, sex, primary site, grade, stage, lymph node removal, chemotherapy record, radiotherapy record, insurance, and marital status in the multivariate Cox proportional hazard model (hazard ratio [HR]= 0. 592; 95% confidence interval [CI] = 0.449–0.782; p = 0.0001). In comparison with chemotherapy and radiation, which resulted in poorer survival rates, surgery considerably improved survival outcomes in urinary bladder SRCC. The nomogram prediction model was built with C-index values of 0.70 and 73 for OS and CSS prediction, respectively. AUC in OS values were 0.77, 0.76, and 0.74, whereas AUC in CSS were 0.83, 0.80, and 0.79 for the 1-, 3-, and 5-year survival nomograms, respectively. CONCLUSION: Surgery was a significant independent predictor of bladder SRCC survival. Patients who underwent surgery had higher CSS and OS than people who did not undergo surgery. Surgery also led to better survival than the combination of the different treatment modalities.
format Online
Article
Text
id pubmed-9003658
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-90036582022-04-13 Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study Alradhi, Mohammed Safi, Mohammed Tao, Shenghua Al-danakh, Abdullah Almoiliqy, Marwan Baldi, Salem Li, Xiancheng Ther Adv Urol Management of Bladder Cancer: What is the evidence? OBJECTIVES: The purpose of this study is to determine the therapeutic value of surgery in individuals with urinary bladder signet ring cell carcinoma (SRCC). Surgery has not been examined as a prognostic factor for urinary bladder cancer (SRCC). MATERIALS AND METHODS: Using the Surveillance, Epidemiology, and End Results program (SEER), patients with urinary bladder SRCC who presented from 1975 to 2018 were included in a retrospective study. The effect of surgical therapy on cause-specific survival (CSS) and overall survival (OS) was examined using univariate and multivariate Cox regression models. We subdivided 595 patients with SRCC into 2 groups, as follows: 496 who underwent surgery; and 99 who did not undergo surgery. RESULTS: Males had high predominance in all cases in both groups (p = 0.04). Moderate and poor differentiation (III–IV) were observed in the majority of patients who underwent surgery (77.2 vs 58.6, p ⩽ 0.001) and had no insurance (p ⩽ 0.001). By using KM, the OS and CSS of the surgery group were found to be significantly better than those of the non-surgery group (p  = 0.001,%) after adjusting for the variables of age, race, sex, primary site, grade, stage, lymph node removal, chemotherapy record, radiotherapy record, insurance, and marital status in the multivariate Cox proportional hazard model (hazard ratio [HR]= 0. 592; 95% confidence interval [CI] = 0.449–0.782; p = 0.0001). In comparison with chemotherapy and radiation, which resulted in poorer survival rates, surgery considerably improved survival outcomes in urinary bladder SRCC. The nomogram prediction model was built with C-index values of 0.70 and 73 for OS and CSS prediction, respectively. AUC in OS values were 0.77, 0.76, and 0.74, whereas AUC in CSS were 0.83, 0.80, and 0.79 for the 1-, 3-, and 5-year survival nomograms, respectively. CONCLUSION: Surgery was a significant independent predictor of bladder SRCC survival. Patients who underwent surgery had higher CSS and OS than people who did not undergo surgery. Surgery also led to better survival than the combination of the different treatment modalities. SAGE Publications 2022-04-07 /pmc/articles/PMC9003658/ /pubmed/35422880 http://dx.doi.org/10.1177/17562872221079473 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Management of Bladder Cancer: What is the evidence?
Alradhi, Mohammed
Safi, Mohammed
Tao, Shenghua
Al-danakh, Abdullah
Almoiliqy, Marwan
Baldi, Salem
Li, Xiancheng
Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study
title Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study
title_full Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study
title_fullStr Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study
title_full_unstemmed Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study
title_short Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study
title_sort surgery improves survival in bladder signet-ring cell carcinoma-a population-based study
topic Management of Bladder Cancer: What is the evidence?
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003658/
https://www.ncbi.nlm.nih.gov/pubmed/35422880
http://dx.doi.org/10.1177/17562872221079473
work_keys_str_mv AT alradhimohammed surgeryimprovessurvivalinbladdersignetringcellcarcinomaapopulationbasedstudy
AT safimohammed surgeryimprovessurvivalinbladdersignetringcellcarcinomaapopulationbasedstudy
AT taoshenghua surgeryimprovessurvivalinbladdersignetringcellcarcinomaapopulationbasedstudy
AT aldanakhabdullah surgeryimprovessurvivalinbladdersignetringcellcarcinomaapopulationbasedstudy
AT almoiliqymarwan surgeryimprovessurvivalinbladdersignetringcellcarcinomaapopulationbasedstudy
AT baldisalem surgeryimprovessurvivalinbladdersignetringcellcarcinomaapopulationbasedstudy
AT lixiancheng surgeryimprovessurvivalinbladdersignetringcellcarcinomaapopulationbasedstudy